policy, genetics

The guidance comes after two years of consulting with hundreds of stakeholders, including indigenous peoples, religious leaders, patient groups, and scientists.

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.

The modification of three babies’ genes by He Jiankui drew widespread criticism from scientists.

All six calves inherited the gene for preventing horn growth, but four also got a piece of the plasmid used to introduce the sequence to their dad—complicating regulatory approval.

The Department of Justice plans to require cheek swabs at the border, with the data then entered in a national criminal database.

A panel finds David Latchman’s “recklessness in the conduct” of the lab and his involvement as an author on problematic papers facilitated the misconduct.

Multiple researchers were aware of He Jiankui’s clinical trial before the news became public in November.

LunaDNA receives Securities and Exchange Commission approval to treat the data as currency.

The European Union says no thanks.

The nationwide experiment will initially include around 100,000 volunteers.

Genetic engineering—once a trigger for federal oversight—is now ushering some modified crops around scrutiny.

The crucial importance of language in the debate over the regulation of direct-to-consumer genetic tests

California mulls a state law that would criminalize the unauthorized sharing, storing, or analyzing of genetic data.

The European Commission takes a major step towards unraveling the secrets of human epigenetics.

A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.

Experts come together to revisit the controversial field of genetics and criminology.